Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy
Authors
- V. Schneider
- L. Zhang
- L. Bullinger
- M. Rojewski
- S. Hofmann
- M. Wiesneth
- H. Schrezenmeier
- M. Götz
- U. Botzenhardt
- T.F.E. Barth
- K. Döhner
- H. Döhner
- J. Greiner
Journal
- Leukemia
Citation
- Leukemia 28 (8): 1759-62